SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2002
OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File No. 0-22780
FEI COMPANY
(Exact name of registrant as specified in its charter)
Oregon |
|
93-0621989 |
(State
or other jurisdiction of |
|
(I.R.S.
Employer Identification |
|
|
|
7451 NW Evergreen Parkway |
|
|
Hillsboro, Oregon |
|
97124-5830 |
(Address of principal executive offices) |
|
(Zip Code) |
|
|
|
(503) 640-7500 |
||
(Registrants telephone number, including area code) |
||
|
|
|
Not applicable |
||
(Former
name, former address and former fiscal year, |
||
|
|
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o
The number of shares of Common Stock outstanding as of August 8, 2002 was 32,428,806.
Part I - Financial Information |
|
|
||
|
|
|
|
|
Item 1. Financial Statements (unaudited) |
|
|
||
|
|
|
|
|
|
Condensed Consolidated Balance Sheets - December 31, 2001 and June 30, 2002 |
|
||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations |
|
|||
|
|
|
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk |
||||
|
|
|
|
|
Part II - Other Information |
|
|
||
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
i
FEI Company and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands, except share data)
(Unaudited)
|
|
December 31, |
|
June 30, |
|
||
Assets |
|
|
|
|
|
||
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
176,862 |
|
$ |
187,105 |
|
Short-term investments |
|
118,814 |
|
61,522 |
|
||
Receivables |
|
81,010 |
|
91,916 |
|
||
Current account with Philips |
|
2,401 |
|
|
|
||
Inventories |
|
76,533 |
|
84,707 |
|
||
Deferred income taxes |
|
16,900 |
|
13,104 |
|
||
Other current assets |
|
7,300 |
|
10,300 |
|
||
|
|
|
|
|
|
||
Total current assets |
|
479,820 |
|
448,654 |
|
||
|
|
|
|
|
|
||
Non-current investments |
|
|
|
48,640 |
|
||
|
|
|
|
|
|
||
Equipment (net of accumulated depreciation of $36,461 at December 31, 2001 and $42,528 at June 30, 2002) |
|
34,526 |
|
39,122 |
|
||
|
|
|
|
|
|
||
Purchased technology, net |
|
30,680 |
|
28,272 |
|
||
|
|
|
|
|
|
||
Goodwill, net |
|
32,497 |
|
32,674 |
|
||
|
|
|
|
|
|
||
Other assets |
|
29,953 |
|
39,319 |
|
||
|
|
|
|
|
|
||
Total Assets |
|
$ |
607,476 |
|
$ |
636,681 |
|
|
|
|
|
|
|
||
Liabilities and Shareholders Equity |
|
|
|
|
|
||
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
||
Accounts payable |
|
$ |
27,569 |
|
$ |
35,417 |
|
Current account with Philips |
|
|
|
4,610 |
|
||
Accrued payroll liabilities |
|
13,042 |
|
10,906 |
|
||
Accrued warranty reserves |
|
18,988 |
|
18,099 |
|
||
Deferred revenue |
|
29,125 |
|
26,033 |
|
||
Income taxes payable |
|
17,804 |
|
17,930 |
|
||
Other current liabilities |
|
24,268 |
|
23,561 |
|
||
|
|
|
|
|
|
||
Total current liabilities |
|
130,796 |
|
136,556 |
|
||
|
|
|
|
|
|
||
Convertible debt |
|
175,000 |
|
175,000 |
|
||
|
|
|
|
|
|
||
Deferred income taxes |
|
4,100 |
|
4,079 |
|
||
|
|
|
|
|
|
||
Other liabilities |
|
1,064 |
|
2,791 |
|
||
|
|
|
|
|
|
||
Commitments and contingencies |
|
|
|
|
|
||
|
|
|
|
|
|
||
Shareholders equity: |
|
|
|
|
|
||
Preferred stock - 500,000 shares authorized; none issued and outstanding |
|
|
|
|
|
||
Common stock - 45,000,000 shares authorized; 32,003,028 and |
|
317,140 |
|
320,001 |
|
||
Note receivable from shareholder |
|
(1,116 |
) |
(1,116 |
) |
||
Retained Earnings (accumulated deficit) |
|
(10,368 |
) |
421 |
|
||
Accumulated other comprehensive loss |
|
(9,140 |
) |
(1,051 |
) |
||
|
|
|
|
|
|
||
Total shareholders equity |
|
296,516 |
|
318,255 |
|
||
|
|
|
|
|
|
||
Total Liabilities and Shareholders Equity |
|
$ |
607,476 |
|
$ |
636,681 |
|
See notes to condensed consolidated financial statements.
1
FEI Company and Subsidiaries
Condensed Consolidated Statements of Operations
(In thousands, except share data)
(Unaudited)
|
|
Thirteen Weeks Ended |
|
Twenty-Six Weeks Ended |
|
||||||||
|
|
July 1, |
|
June 30, |
|
July 1, |
|
June 30, |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Net sales |
|
$ |
94,042 |
|
$ |
87,881 |
|
$ |
187,557 |
|
$ |
172,379 |
|
|
|
|
|
|
|
|
|
|
|
||||
Cost of sales |
|
46,352 |
|
47,967 |
|
94,924 |
|
92,619 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Gross profit |
|
47,690 |
|
39,914 |
|
92,633 |
|
79,760 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Operating expenses: |
|
|
|
|
|
|
|
|
|
||||
Research and development |
|
11,173 |
|
10,587 |
|
20,470 |
|
21,326 |
|
||||
Selling, general and administrative |
|
18,084 |
|
17,965 |
|
35,308 |
|
35,300 |
|
||||
Merger costs |
|
|
|
1,117 |
|
|
|
1,117 |
|
||||
Amortization of purchased goodwill and technology |
|
1,648 |
|
1,204 |
|
3,186 |
|
2,408 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Total operating expenses |
|
30,905 |
|
30,873 |
|
58,964 |
|
60,151 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Operating income |
|
16,785 |
|
9,041 |
|
33,669 |
|
19,609 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Other income (expense): |
|
|
|
|
|
|
|
|
|
||||
Interest income |
|
446 |
|
1,925 |
|
715 |
|
3,546 |
|
||||
Interest expense |
|
(579 |
) |
(2,813 |
) |
(889 |
) |
(5,314 |
) |
||||
Valuation adjustment |
|
(3,718 |
) |
|
|
(3,718 |
) |
|
|
||||
Other |
|
1,127 |
|
(497 |
) |
973 |
|
(851 |
) |
||||
Total other expense, net |
|
(2,724 |
) |
(1,385 |
) |
(2,919 |
) |
(2,619 |
) |
||||
|
|
|
|
|
|
|
|
|
|
||||
Income before taxes |
|
14,061 |
|
7,656 |
|
30,750 |
|
16,990 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Tax expense |
|
5,493 |
|
2,794 |
|
11,959 |
|
6,201 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
8,568 |
|
$ |
4,862 |
|
$ |
18,791 |
|
$ |
10,789 |
|
|
|
|
|
|
|
|
|
|
|
||||
Per share data: |
|
|
|
|
|
|
|
|
|
||||
Basic earnings per share |
|
$ |
0.29 |
|
$ |
0.15 |
|
$ |
0.64 |
|
$ |
0.33 |
|
Diluted earnings per share |
|
$ |
0.27 |
|
$ |
0.15 |
|
$ |
0.61 |
|
$ |
0.32 |
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
||||
Basic |
|
29,951,008 |
|
32,340,964 |
|
29,358,931 |
|
32,219,136 |
|
||||
Diluted |
|
31,335,653 |
|
33,410,764 |
|
30,697,322 |
|
33,420,784 |
|
See notes to condensed consolidated financial statements.
2
FEI Company and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income
(In thousands)
(Unaudited)
|
|
Thirteen Weeks Ended |
|
Twenty-Six Weeks Ended |
|
||||||||
|
|
July 1, |
|
June 30, |
|
July 1, |
|
June 30, |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
8,568 |
|
$ |
4,862 |
|
$ |
18,791 |
|
$ |
10,789 |
|
|
|
|
|
|
|
|
|
|
|
||||
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Foreign currency translation adjustment, zero taxes provided |
|
(1,142 |
) |
9,284 |
|
(2,806 |
) |
8,089 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Comprehensive income |
|
$ |
7,426 |
|
$ |
14,146 |
|
$ |
15,985 |
|
$ |
18,878 |
|
See notes to condensed consolidated financial statements.
3
FEI Company and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
|
|
Twenty-Six Weeks Ended |
|
||||
|
|
July 1, |
|
June 30, |
|
||
Cash flows from operating activities: |
|
|
|
|
|
||
Net income |
|
$ |
18,791 |
|
$ |
10,789 |
|
Adjustments to reconcile net income to net cash flows from operating activities: |
|
|
|
|
|
||
Depreciation |
|
5,439 |
|
5,918 |
|
||
Amortization |
|
4,156 |
|
3,720 |
|
||
Loss on Retirement of fixed assets and demonstration systems |
|
319 |
|
209 |
|
||
Deferred income taxes |
|
(6,219 |
) |
3,775 |
|
||
Valuation adjustment |
|
3,718 |
|
|
|
||
Decrease (increase) in assets: |
|
|
|
|
|
||
Receivables |
|
2,221 |
|
(6,649 |
) |
||
Current account with Philips |
|
3,885 |
|
7,667 |
|
||
Inventories |
|
(15,300 |
) |
1,567 |
|
||
Other assets |
|
(4,327 |
) |
(12,049 |
) |
||
Increase (decrease) in liabilities: |
|
|
|
|
|
||
Accounts payable |
|
3,277 |
|
5,032 |
|
||
Accrued payroll liabilities |
|
(1,357 |
) |
(2,604 |
) |
||
Accrued warranty reserves |
|
1,290 |
|
(1,987 |
) |
||
Deferred revenue |
|
9,785 |
|
(4,787 |
) |
||
Other liabilities |
|
4,455 |
|
(1,239 |
) |
||
|
|
|
|
|
|
||
Net cash provided by operating activities |
|
30,133 |
|
9,365 |
|
||
|
|
|
|
|
|
||
Cash flows from investing activities: |
|
|
|
|
|
||
Acquisition of equipment |
|
(12,421 |
) |
(10,265 |
) |
||
Net change in short-term investments |
|
|
|
57,293 |
|
||
Purchase of non-current investments |
|
|
|
(48,640 |
) |
||
Acquisition of patents |
|
(200 |
) |
(85 |
) |
||
Investment in unconsolidated affiliate |
|
|
|
(990 |
) |
||
Acquisition of businesses, net of cash acquired |
|
|
|
(1,052 |
) |
||
Investment in software development |
|
(524 |
) |
(1,503 |
) |
||
|
|
|
|
|
|
||
Net cash used in investing activities |
|
(13,145 |
) |
(5,242 |
) |
||
|
|
|
|
|
|
||
Cash flows from financing activities: |
|
|
|
|
|
||
Net repayments of bank lines of credit |
|
(1,534 |
) |
|
|
||
Proceeds of borrowings from Philips |
|
(16,141 |
) |
|
|
||
Proceeds from secondary offering, net of expenses |
|
88,065 |
|
|
|
||
Proceeds from employee stock plans |
|
1,971 |
|
2,861 |
|
||
|
|
|
|
|
|
||
Net cash provided by financing activities |
|
72,361 |
|
2,861 |
|
||
|
|
|
|
|
|
||
Effect of exchange rate changes |
|
(2,806 |
) |
3,259 |
|
||
|
|
|
|
|
|
||
Net increase in cash and cash equivalents |
|
86,543 |
|
10,243 |
|
||
|
|
|
|
|
|
||
Cash and cash equivalents, beginning of period |
|
24,031 |
|
176,862 |
|
||
|
|
|
|
|
|
||
Cash and cash equivalents, end of period |
|
$ |
110,574 |
|
$ |
187,105 |
|
See notes to condensed consolidated financial statements.
4
FEI COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands)
(Unaudited)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Business FEI Company and its wholly-owned subsidiaries (FEI or the Company) design, manufacture, market and service products based on focused charged particle beam technology. The Companys products include transmission electron microscopes (TEMs), scanning electron microscopes (SEMs), focused ion-beam systems (FIBs) and DualBeam systems that combine a FIB column and a SEM column on a single platform. The Company also designs, manufactures and sells some of the components of electron microscopes and FIBs to other manufacturers. The Company has research, development and manufacturing operations in Hillsboro, Oregon; Peabody, Massachusetts; Sunnyvale, California; Eindhoven, The Netherlands; Munich, Germany; and Brno, Czech Republic. Sales and service operations are conducted in the United States of America (U.S.) and 19 other countries located throughout North America, Europe and the Asia Pacific Region. The Company also sells its products through independent agents and representatives in various additional countries. The Companys products are sold to semiconductor manufacturers, thin film head manufacturers in the data storage industry and to industrial, institutional and research organizations in the life sciences and material sciences fields.
Basis of Presentation The consolidated financial statements include the accounts of FEI Company and all of its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
The accompanying condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments and purchase accounting adjustments, considered necessary for fair presentation have been included. The results of operations for the thirteen and twenty-six weeks ended June 30, 2002 are not necessarily indicative of the results to be expected for the full year. For further information, refer to the consolidated financial statements and notes thereto included in the Companys Annual Report on Form 10-K for the year ended December 31, 2001.
Reclassifications Certain reclassifications have been made to the prior year financial statements to conform to the current year presentation.
Recently Issued Accounting Pronouncements The Company adopted Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and Other Intangible Assets on January 1, 2002. The statement requires discontinuing the amortization of goodwill and other intangible assets with indefinite useful lives. Instead, these assets are to be tested periodically for impairment and written down to their fair market value as necessary. Other than the cessation of amortization of goodwill, the adoption of SFAS No. 142 had no effect on the Companys results of operations or cash flows for the thirteen and twenty-six weeks ended June 30, 2002. The amount of goodwill amortization expense was $896 for the thirteen weeks and $1,683 for the twenty-six weeks ended July 1, 2001. As part of the adoption of SFAS No. 142, the Company was required to complete an impairment test on existing goodwill by June 30, 2002 and annually thereafter. The Company completed this impairment test during the thirteen weeks ended June 30, 2002 and determined there was no impairment to its existing goodwill. SFAS No. 142 did not affect the accounting treatment for the Companys other purchased technology such as existing technology and in-process research and development.
SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, was issued in August 2001 and became effective January 1, 2002. SFAS No. 144 supersedes SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of and APB Opinion No. 30, Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions. SFAS No. 144 establishes a single accounting model for long-lived assets to be disposed of by sale and expands on the guidance provided by SFAS No. 121 with respect to cash flow estimations. The adoption of
5
SFAS No. 144 did not have a material effect on the Companys financial position, results of operations or cash flows.
SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections, was issued in April 2002. This statement rescinds SFAS No. 4 and its amendments, which required all gains and losses from extinguishments of debt to be aggregated and, if material, classified as an extraordinary item, net of related income tax effects. The Company does not believe that the adoption of SFAS No. 145 will have a material effect on its financial position, results of operations or cash flows.
On July 30, 2002, FASB issued SFAS no. 146, Accounting for Costs Associated with Exit or Disposal Activities. SFAS No. 146 requires companies recognize costs associated with exit or disposal activities when they are incurred rather than at the date of a commitment to an exit or disposal plan. SFAS No. 146 is to be applied prospectively to exit or disposal activities initiated after December 31, 2002. The Company does not believe the adoption of this statement will have a material impact on its financial position, results of operations, or cash flows.
Earnings per Share The difference between basic and diluted net income per share is a result of the dilutive effect of stock options, which are considered potential common shares. The difference between the number of shares used in the calculation of basic and diluted net income per share is as follows:
|
|
Thirteen Weeks Ended |
|
Twenty-Six Weeks Ended |
|
||||
|
|
July 1, 2001 |
|
June 30, 2002 |
|
July 1, 2001 |
|
June 30, 2002 |
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic |
|
29,951,008 |
|
32,340,964 |
|
29,358,931 |
|
32,219,136 |
|
Dilutive effect of stock options calculated using the treasury stock method |
|
1,384,645 |
|
1,069,800 |
|
1,338,391 |
|
1,201,648 |
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - diluted |
|
31,335,653 |
|
33,410,764 |
|
30,697,322 |
|
33,420,784 |
|
For the thirteen weeks ended July 1, 2001 and June 30, 2002 14,195 and 1,183,902 shares issuable upon the exercise of outstanding stock options were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive. For the twenty-six weeks ended July 1, 2001 and June 30, 2002, 172,531 and 712,001 shares issuable upon the exercise of outstanding stock options were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive. For the thirteen and twenty-six weeks ended June 30, 2002, 3,533,926 shares issuable upon the potential conversion of the Companys convertible debt were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive.
Supplemental Cash Flow Information Cash paid for interest totaled $251 in the twenty-six weeks ended July 1, 2001 and $5,628 in the twenty-six weeks ended June 30, 2002. Cash paid for income taxes totaled $12,926 in the twenty-six weeks ended July 1, 2001 and $2,553 in the twenty-six weeks ended June 30, 2002.
2. MERGERS AND ACQUISITIONS
2001 Acquisitions - On April 24, 2001, the Company acquired all of the outstanding common stock of Deschutes Corporation (Deschutes), a manufacturer of focused charged particle beam systems, in a transaction accounted for under the purchase method. Deschutes results of operations are included in the consolidated financial statements for the period subsequent to April 24, 2001. The original purchase price of $3,012 included $650 of cash, 50,628 shares of FEI common stock valued at $1,279 and $1,083 of liabilities assumed. In April, 2002, an additional $200 was paid (consisting of 3,957 shares of the Companys common stock, valued at $100, and $100 of cash) upon the meeting of milestones. The purchase price may be increased by an additional amount of up to $400 (consisting of 7,915 shares of the Companys common stock, valued at $200, and $200 of cash) if certain milestones are met.
On August 13, 2001, the Company purchased all of the assets and assumed certain liabilities of
6
Surface/Interface, Inc. (Surface/Interface), a supplier of stylus nanoprofilometry systems, in a transaction accounted for under the purchase method. Activity of the Surface/Interface business is included in the consolidated financial statements for the period subsequent to August 13, 2001. The purchase price of $12,365 included $750 cash, 131,880 shares of FEI common stock valued at $5,009, the assumption of $4,091 of Surface/Interfaces liabilities and the Companys previous investment and advances to Surface/Interface of $2,515. The Companys Chief Executive Officer and members of his family held an ownership interest in Surface/Interface up to the date of the acquisition in August 2001.
For these acquisitions, management estimated the fair value of the intangible assets, inventory, and equipment acquired in order to allocate the total purchase price to the assets acquired and liabilities assumed. To determine the value of the technology and product lines acquired, management projected product revenues, gross margins, operating expenses, future research and development costs, income taxes and returns on requisite assets. The resulting operating income projections were discounted to a net present value. This approach was applied to existing technology as well as to research and development projects which had not yet been proven technologically feasible and which had not yet generated revenue at the date of the acquisition. For existing technology product lines, the discount rate used was 25 to 30 percent representing managements estimate of the weighted average cost of capital for the acquired businesses. For research projects on products which had not yet been proven technologically feasible, the discount rate applied was 32 to 37 percent, reflecting the estimated equity cost of capital plus a premium for the risk and uncertainty associated with successful completion and market acceptance for such unproven products.
The existing technology is being amortized over its estimated useful life of five years. It is possible that estimates of anticipated future gross revenues, the remaining estimated economic life of products or technologies, or both, may be reduced due to competitive pressures or other factors. Management periodically evaluates the remaining economic useful lives and amortization periods for these intangible assets.
2002 Acquisitions - On June 10, 2002, the Company purchased all of the assets and assumed certain liabilities of Atomika, Inc., a supplier of secondary ion mass spectrometry equipment, in a transaction accounted for under the purchase method. Atomika, Inc. was under bankruptcy protection at the time of the transaction. Activity of this business is included in the consolidated financial statements for the period subsequent to June 10, 2002. The purchase price of $2,657 included $1,052 cash, and the assumption of $1,605 of liabilities. The total purchase price of these assets was allocated $2,605 to current assets and $52 to equipment. There were no intangible assets identified in the purchase price allocation for this asset purchase.
Purchased Goodwill and Technology - Purchased goodwill and technology consisted of the following:
|
|
Amortization |
|
December 31, |
|
June 30, |
|
||
|
|
Period |
|
2001 |
|
2002 |
|
||
Existing technology from PEO Combination, net of amortization of $6,642 and $7,239, respectively |
|
12 years |
|
$ |
9,848 |
|
$ |
9,161 |
|
Existing technology from Micrion acquisition, net of amortization of $3,914 and $4,728, respectively |
|
10 years |
|
12,363 |
|
11,549 |
|
||
Existing technology from other acquisitions, net of amortization of $605 and $1,512, respectively |
|
5 years |
|
8,469 |
|
7,562 |
|
||
Purchased technology, net |
|
|
|
$ |
30,680 |
|
$ |
28,272 |
|
|
|
|
|
|
|
|
|
||
Goodwill from PEO Combination |
|
* |
|
$ |
11,561 |
|
$ |
11,627 |
|
Goodwill from Micrion acquisition |
|
* |
|
19,520 |
|
19,431 |
|
||
Goodwill from other acquisitions |
|
* |
|
1,416 |
|
1,616 |
|
||
Goodwill, net |
|
|
|
$ |
32,497 |
|
$ |
32,674 |
|
* Amortization of goodwill was discontinued effective January 1, 2002 in accordance with SFAS No. 142.
As required by SFAS No. 142, the results for the thirteen and twenty-six weeks ended July 1, 2001 have not
7
been restated. A reconciliation of net income as if SFAS No. 142 had been adopted January 1, 2001 is presented below.
|
|
Thirteen Weeks |
|
Twenty-six Weeks |
|
||
|
|
Ended |
|
Ended |
|
||
|
|
July 1, 2001 |
|
July 1, 2001 |
|
||
Reported net income |
|
$ |
8,568 |
|
$ |
18,791 |
|
Add back goodwill amortization, no tax effect |
|
896 |
|
1,683 |
|
||
|
|
|
|
|
|
||
Adjusted net income |
|
$ |
9,464 |
|
$ |
20,474 |
|
|
|
|
|
|
|
||
Basic earnings per share: |
|
|
|
|
|
||
Reported earnings per share |
|
$ |
0.29 |
|
$ |
0.64 |
|
Adjusted earnings per share |
|
$ |
0.32 |
|
$ |
0.70 |
|
|
|
|
|
|
|
||
Diluted earnings per share: |
|
|
|
|
|
||
Reported earnings per share |
|
$ |
0.27 |
|
$ |
0.61 |
|
Adjusted earnings per share |
|
$ |
0.30 |
|
$ |
0.67 |
|
3. RECEIVABLES
Receivables consisted of the following:
|
|
December 31, |
|
June 30, |
|
||
|
|
2001 |
|
2002 |
|
||
|
|
|
|
|
|
||
Trade accounts receivable |
|
$ |
84,531 |
|
$ |
95,779 |
|
Allowance for doubtful accounts |
|
(3,521 |
) |
(3,863 |
) |
||
|
|
|
|
|
|
||
Receivables |
|
$ |
81,010 |
|
$ |
91,916 |
|
8
4. INVENTORIES
Inventories consisted of the following:
|
|
December 31, |
|
June 30, |
|
||
|
|
2001 |
|
2002 |
|
||
|
|
|
|
|
|
||
Raw materials and assembled parts |
|
$ |
37,006 |
|
$ |
36,570 |
|
Service inventories, estimated current requirements |
|
7,247 |
|
8,501 |
|
||
Work in process |
|
24,253 |
|
29,601 |
|
||
Finished goods |
|
18,604 |
|
19,393 |
|
||
|
|
87,110 |
|
94,065 |
|
||
Reserve for excess and obsolete inventory |
|
(10,577 |
) |
(9,358 |
) |
||
|
|
|
|
|
|
||
Total inventories |
|
$ |
76,533 |
|
$ |
84,707 |
|
|
|
|
|
|
|
During the 26 weeks ended June 30, 2002, the Company disposed of $2,971 of inventory and charged the cost against the related excess and obsolescence reserve.
5. OTHER ASSETS
Other assets consisted of the following:
|
|
December 31, |
|
June 30, |
|
||
|
|
2001 |
|
2002 |
|
||
|
|
|
|
|
|
||
Service inventories, estimated noncurrent requirements, net of excess and obsolescence reserves of $9,686 and $9,360, respectively |
|
$ |
17,301 |
|
$ |
22,992 |
|
Capitalized software development costs, net of amortization of $5,016 and $3,732, respectively |
|
5,175 |
|
5,971 |
|
||
Debt issuance costs, net of amortization of $350 and $772, respectively |
|
5,532 |
|
5,129 |
|
||
Patents, net of amortization of $163 and $174, respectively |
|
358 |
|
432 |
|
||
Investment in unconsolidated affiliates |
|
|
|
990 |
|
||
Deposits and other |
|
1,587 |
|
3,805 |
|
||
|
|
|
|
|
|
||
Total other assets |
|
$ |
29,953 |
|
$ |
39,319 |
|
During the 26 weeks ended June 30, 2002, the Company disposed of $2,076 of non-current service inventory and charged the cost against the related excess and obsolescence reserve.
Software development costs capitalized were $192 and $524 during the thirteen and twenty-six weeks ended July 1, 2001 and $810 and $1,503 during the thirteen and twenty-six weeks ended June 30, 2002. Amortization of capitalized software development costs was $464 and $921 for the thirteen and twenty-six weeks ended July 1, 2001 and $412 and $879 for the thirteen and twenty-six weeks ended June 30, 2002.
In March 2002, the Company purchased 529,189 shares of Series B Preferred stock and 226,244 warrants to purchase Series B Preferred stock of Neocera, Inc., a start-up company that manufactures metrology equipment for the semiconductor manufacturing market. The total cost of the investment was $990.
6. CREDIT FACILITIES
The Company also maintains a $10,000 unsecured and uncommitted bank borrowing facility in the U.S. and certain limited bank facilities in selected foreign countries. In addition, the Company maintains a $5,000 unsecured and uncommitted bank facility in the U.S. and a $4,902 unsecured and uncommitted bank facility in The Netherlands for the purpose of issuing standby letters of credit and bank guarantees. At June 30, 2002, the Company had outstanding
9
standby letters of credit and bank guarantees totaling approximately $1,903 to secure customer advance deposits under these bank facilities. The Company also had outstanding at June 30, 2002, $10,537 of foreign bank guarantees that are secured by cash balances.
On August 3, 2001, the Company issued $175 million of convertible subordinated notes, due August 15, 2008, through a private placement. The notes are redeemable at the Companys option beginning in 2004, or earlier if the price of the Companys common stock exceeds specified levels. The notes bear interest at 5.5%, payable semi-annually in February and August. The notes are convertible into common stock of the Company, at the note holders option, at a price of $49.52 per share.
7. SHAREHOLDERS EQUITY
The Company issued 58,493 shares of common stock to employees under its Employee Stock Purchase Plan during the twenty-six weeks ended July 1, 2001 and 59,405 shares during the twenty-six weeks ended June 30, 2002. Options to purchase 103,862 shares of common stock were exercised during the twenty-six weeks ended July 1, 2001 and options to purchase 150,040 shares of common stock were exercised during the twenty-six weeks ended June 30, 2002.
On February 21, 1997, the Company acquired substantially all of the assets and liabilities of the electron optics business of Koninklijke Philips Electronics NV (Philips), in a transaction accounted for as a reverse acquisition (the PEO Combination). Philips received 55 percent of the then outstanding common stock of the Company in the exchange. As part of the PEO Combination, the Company agreed to issue to Philips additional shares of common stock of the Company whenever stock options that were outstanding on the date of the PEO Combination are exercised. Any such additional shares are issued at a rate of approximately 1.22 shares to Philips for each share issued on exercise of these options. The Company receives no additional consideration for these shares issued to Philips under this agreement. During the twenty-six weeks ended June 30, 2002, the Company issued 131,293 shares of its common stock to Philips pursuant to this agreement. There were no such shares issued during the twenty-six weeks ended July 1, 2001. As of June 30, 2002, 326,487 shares of the Companys common stock are potentially issuable and reserved for issuance to Philips as a result of this agreement.
On May 22, 2001, the Company completed a public offering of 3,066,666 shares of FEI common stock sold by the Company and 6,133,334 shares of FEI common stock sold by Philips. Proceeds to the Company, net of underwriting discounts, commissions and offering expenses, totaled $87,994. At completion of the offering, Philips ownership of FEI common stock was reduced to approximately 8.1 million shares, or 25.6% of the total FEI common shares then outstanding, compared with 49.7% ownership prior to the offering.
8. RELATED-PARTY ACTIVITY
Relationship with Philips Philips maintained majority control of FEI from February 21, 1997 until May 22, 2001, when its ownership was reduced through a secondary public stock offering (see Note 7).
The Company purchases various goods and services from Philips and Philips also purchases goods and services from the Company. The Company and Philips entered into an agreement, effective December 31, 2000, that clarifies certain relationships and transactions between the parties. Certain terms of the agreement became effective May 22, 2001 or 120 days after May 22, 2001, the day Philips ownership fell below 45% of the Companys outstanding common stock. The agreement addresses, among other things, patents and intellectual property, research and development services, use of the Philips name and trademark, participation in Philips insurance programs and the Philips credit facility. Under the agreement, the Company no longer participates in certain Philips sponsored or administered programs. The Company continues to purchase certain of these services from Philips and certain other of these services are procured from other suppliers. The cost to procure these services from other suppliers and from Philips subsequent to May 22, 2001 is in excess of the amounts previously paid to Philips.
Prior to September 1, 2001, the Company participated in certain pension and collective bargaining
10
arrangements made by Philips in The Netherlands. The Company has entered into its own pension and collective bargaining arrangements in The Netherlands effective September 1, 2001. The cost of these employee benefit arrangements in The Netherlands is in excess of the amounts previously paid under the Philips arrangements. Under terms of the separation agreement with Philips dated December 31, 2000, Philips will pay up to $6,000 to the Company over a three-year period to reduce the effect of these and other increased costs. These payments would terminate on a change of control of FEI, as defined in the agreement.
Due to the anticipated merger discussed in Note 11 and related amendments to the agreements with Philips, the Company now expects these separation payments to end upon closing of the merger sometime in the fourth quarter of 2002. Based on this change in circumstance, the Company revised its estimate of the amount to be received from Philips and revised the estimated amortization period from 31 to 16 months. Accordingly, an additional $1,140 of the payments under the separation agreement were recognized during the thirteen weeks ended June 30, 2002. During the thirteen and twenty-six weeks ended June 30, 2002, the Company recognized a total of $1,735 and $2,316, respectively, of this amount as an offset to expenses under this arrangement.
Current Accounts with Philips Current accounts with Philips represent accounts receivable and accounts payable between the Company and other Philips units for deliveries of goods, materials and services.
Current accounts with Philips consisted of the following:
|
|
December 31, |
|
June 30, |
|
||
|
|
2001 |
|
2002 |
|
||
|
|
|
|
|
|
||
Current accounts receivable |
|
$ |
5,945 |
|
$ |
1,910 |
|
Current accounts payable |
|
(3,544 |
) |
(6,520 |
) |
||
|
|
|
|
|
|
||
Net current accounts with Philips |
|
$ |
2,401 |
|
$ |
(4,610 |
) |
Accurel The Companys President and Chief Executive Officer owns a 50 percent interest in Accurel Systems International Corp. (Accurel), a provider of metrology services to the semiconductor and data storage markets. In the thirteen weeks ended March 31, 2002, the Company sold two systems to Accurel for an aggregate of $2,191. Accurel was extended payment terms of 5 years with 7% interest for one system and 3 years with 6.5% interest for the other. These transactions were reviewed and approved by the Companys board of directors. There were no system sales to Accurel in the thirteen weeks ended June 30, 2002. The Company also provides service to Accurel on several of the Companys products used by Accurel. Service revenue from Accurel was $75 and $186 in the thirteen and twenty-six weeks ended July 1, 2001 and $102 and $186 in the thirteen and twenty-six weeks ended June 30, 2002. The Company has also guaranteed certain third party leases of Accurel, up to a maximum of $500 as of June 30, 2002.
Consulting Agreement During the twenty-six weeks ended June 30, 2002 the Company paid $44 to Shaunt Sarkissian, the son of FEIs President and Chief Executive Officer, under a consulting agreement entered into in January 2002.
Stock Purchase Loan On June 25, 1998, the Company loaned Vahe Sarkissian, FEIs President and Chief Executive Officer, $1,116 for the purchase of restricted stock. The loan was originally due June 25, 2002 and bore interest at a rate of 5.58%. Effective June 25, 2002, the Companys board of directors approved an amendment to the loan to extend the due date of the loan to June 25, 2005 and to increase the interest rate to 5.75%.
11
9. SEGMENT INFORMATION
The Company operates in four business segments. The Microelectronics segment manufactures and markets FIBs and DualBeam systems. Microelectronics segment products are sold primarily to the semiconductor and data storage markets, with additional sales to the industry and institute markets. The Electron Optics segment manufactures and markets SEMs and TEMs. Electron Optics products are sold in the industry and institute markets to materials and life sciences customers, as well as in the semiconductor and data storage markets. The Components segment manufactures and markets electron and ion emitters, focusing columns and components thereof. These components are used in the Companys FIB, DualBeam, SEM and TEM systems and are also sold to other manufacturers. The Customer Service segment services the Companys worldwide installed base of products, predominantly under service contracts.
The following table summarizes various financial amounts for each of the Companys business segments:
|
|
|
|
|
|
|
|
|
|
Corporate |
|
|
|
||||||
|
|
Micro- |
|
Electron |
|
|
|
Customer |
|
and |
|
|
|
||||||
Twenty-Six Weeks Ended |
|
electronics |
|
Optics |
|
Components |
|
Service |
|
Eliminations |
|
Total |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
July 1, 2001: |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Sales to external customers |
|
$ |
92,820 |
|
$ |
58,725 |
|
$ |
9,317 |
|
$ |
26,695 |
|
$ |
|
|
$ |
187,557 |
|
Inter-segment sales |
|
1,082 |
|
8,957 |
|
4,529 |
|
|
|
(14,568 |
) |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total sales |
|
93,902 |
|
67,682 |
|
13,846 |
|
26,695 |
|
(14,568 |
) |
187,557 |
|
||||||
Operating income (loss) |
|
27,388 |
|
6,605 |
|
1,861 |
|
1,796 |
|
(3,981 |
) |
33,669 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
June 30, 2002: |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Sales to external customers |
|
68,850 |
|
66,682 |
|
5,703 |
|
31,144 |
|
|
|
172,379 |
|
||||||
Inter-segment sales |
|
789 |
|
8,684 |
|
2,905 |
|
|
|
(12,378 |
) |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total sales |
|
69,639 |
|
75,366 |
|
8,608 |
|
31,144 |
|
(12,378 |
) |
172,379 |
|
||||||
Operating income (loss) |
|
7,908 |
|
12,367 |
|
1,747 |
|
3,216 |
|
(5,629 |
) |
19,609 |
|
||||||
Inter-segment sales are shown at cost, with no markup for gross profit within the selling segment, and are eliminated in consolidation. Corporate administration expenses and amortization of purchased goodwill and technology are not allocated to the Companys business segments.
10. COMMITMENTS AND CONTINGENCIES
The Company is a party to litigation arising in the ordinary course of business. In the opinion of management, these actions will not have a material adverse effect on the Companys financial position, results of operations or cash flows.
11. SUBSEQUENT EVENTS
On July 11, 2002, FEI entered into an Agreement and Plan of Merger (the Merger Agreement) by and among Veeco Instruments Inc., Venice Acquisition Corp., a wholly owned subsidiary of Veeco and FEI. Pursuant to the Merger Agreement, Venice Acquisition will merge with and into FEI, with the result that FEI shall be the surviving corporation and shall become a wholly owned subsidiary of Veeco. As a result of the merger, each share of FEI common stock issued and outstanding immediately prior to the effective time of the merger shall be converted into the right to receive 1.355 shares of Veeco common stock. In addition, Veeco will assume all options or other rights to purchase capital stock of FEI outstanding under FEIs existing stock option plans, including FEIs stock purchase plans and FEIs convertible debt. The consummation of the merger is subject to the approval of the shareholders of FEI and Veeco, expiration or termination of certain waiting periods under United States and applicable foreign antitrust laws and other customary closing conditions. On August 12, 2002, the Antitrust Division
12
of the Department of Justice contacted the Company and advised it that it intends to conduct a preliminary inquiry into the transaction. The merger is intended to be a tax-free reorganization under Section 368(a) of the Internal Revenue Code of 1986, as amended.
On July 30, 2002 the Company purchased a 27 acre site and 180,000 square feet of office and manufacturing space in Hillsboro, Oregon. Including improvements, the total investment in the new location is expected to be approximately $23,000.
13
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
We are a leading supplier of equipment and solutions to the high growth segments of the semiconductor, data storage and industry and institute markets. Our solutions are based on a combination of patented and proprietary technologies that produce highly focused electron and ion beams. These solutions enable our customers to view and analyze structures in three dimensions and to measure, analyze, diagnose and modify deep sub-micron and atomic structures below the surface in semiconductor wafers and devices, data storage components and biological and industrial materials. This enables our customers to develop products faster, control manufacturing processes better and improve production yields.
We refer to our comprehensive suite of products for three dimensional structural process measurement and analysis as Structural Process Management solutions. These solutions include focused ion beam, or FIB, equipment, scanning electron microscopes, or SEMs, transmission electron microscopes, or TEMs, and DualBeam systems, which combine a FIB column and a SEM column on a single platform. Our customers include leading semiconductor and data storage manufacturers, as well as educational and research institutions and industrial companies located throughout the world. We also design, manufacture and sell components of electron microscopes and FIB systems to a limited number of original equipment manufacturer, or OEM, customers. We have research, development and manufacturing operations located in Hillsboro, Oregon; Peabody, Massachusetts; Sunnyvale, California; Eindhoven, The Netherlands; Munich, Germany; and Brno, Czech Republic. We have sales and service operations in the U.S. and 18 other countries located throughout North America, Europe and the Asia Pacific region. We also use independent agents to sell some of our products in various additional countries.
FEI was founded in 1971 to design and manufacture charged particle emitters (ion and electron sources). We began manufacturing and selling ion and electron focusing columns in the early 1980s and began manufacturing FIB workstations in 1989. In 1993 we manufactured and sold our first DualBeam systems. In 1997 we acquired substantially all of the assets and liabilities of Philips electron optics business, a manufacturer of electron microscopes headquartered in Eindhoven, The Netherlands, in exchange for 55% of our common stock outstanding after issuance. This transaction was accounted for as a reverse acquisition and, as a result, we became a majority owned subsidiary of Philips. The combination with Philips gave us expanded research and development capabilities, increased manufacturing capacity, a worldwide sales and service organization and additional financial resources. In 1999 we acquired Micrion Corporation, a manufacturer of single beam FIB systems headquartered in Peabody, Massachusetts. The acquisition of Micrion broadened our product lines, added research and development strength and expanded our sales and service capabilities in the U.S., Japan and Taiwan. We expect to continue to expand our business in the future through internal growth and strategic acquisitions and partnerships. On July 12, 2002, we announced that we had entered into an agreement and plan of merger with Veeco Instruments, Inc., or Veeco. The merger is expected to close in the fourth quarter of 2002, assuming shareholder and regulatory approvals. Please read Agreement and Plan of Merger with Veeco Instruments below.
Our standard billing terms usually include a holdback of 10 to 20 percent of the total selling price until completion of the installation and final acceptance of our equipment at the customers site. We do not recognize the portion of revenue related to installation and final acceptance until the installation and final acceptance are completed. This policy is in accordance with U.S. Securities and Exchange Commission Staff Accounting Bulletin No. 101, Revenue Recognition in Financial Statements or SAB 101. We expect to continue to experience volatility in our reported revenues due to the timing of revenue recognition under SAB 101. We also receive revenue from services provided to our customers. Revenue from time and materials based service arrangements is recognized as the service is performed. Revenue from service contracts is recognized ratably over the term of the service contracts.
The sales cycle for our systems typically ranges from 3 to 12 months, and can be longer when our customers are evaluating new applications of our technology. Due to the length of these cycles, we invest heavily in research and development and in sales and marketing in advance of generating revenue related to these investments. Additionally, we sometimes loan equipment to customers for their use in evaluating our products. We have also engaged in joint application development arrangements with some of our customers. We make no assurances that these efforts will result in the sale of our equipment to these customers. We expect to continue these practices in the
14
future.
Our customer base is diverse, but we have historically derived a significant portion of our revenue from sales to a few key customers, and we expect that trend to continue. Sales to our top 10 customers accounted for 29% of our total net sales in 2001. A significant portion of our revenue has been derived from customers outside of the U.S., and we expect that trend to continue. Total net sales outside the U.S. were 57% in 2001 and 56% in the first half of 2002.
Many of our microelectronics and electron optics products carry high sales values. Our systems range in list price from about $0.1 million to $4.2 million. We have derived a substantial portion of our revenue from the sale of a relatively small number of units, and we expect that trend to continue. As a result, the timing of revenue recognition from a single order could have a significant impact on our net sales and operating results in a given reporting period. A substantial portion of our net sales has generally been realized near the end of each quarter and sales of electron optics products to governmentfunded customers have generally been significantly higher in the fourth quarter of the calendar year. Accordingly, delays in shipments near the end of a quarter could have a substantial negative effect on operating results for that quarter. Announcements by our competitors or us of new products and technologies could cause customers to defer purchases of our existing systems, which could also have a material adverse effect on our business, financial condition and results of operations.
In addition to the U.S. dollar, we conduct significant business in euros, Japanese yen, British pounds and Czech korunas. Because of our substantial research, development and manufacturing operations in Europe, we incur a greater proportion of our costs in Europe than the revenue we derive from that geographic region. Our raw materials, labor and other manufacturing costs are primarily denominated in U.S. dollars, euros and Czech korunas. This situation has the effect of improving our gross margins and results of operations when the dollar strengthens in relation to the euro or koruna, as was the case in 2001 and the first quarter of 2002. A weakening of the dollar in relation to the euro or Czech koruna would have an adverse effect on our reported results of operations, as was the case in the second quarter of 2002. Movement of Asian currencies in relation to the dollar and euro can also affect our reported sales and results of operations because we derive a greater proportion of revenue from the Asia Pacific region than the costs we incur there. In addition, several of our competitors are based in Japan and a weakening of the Japanese yen has the effect of lowering their prices relative to ours. We attempt to mitigate our currency translation and transaction exposures by using forward exchange contracts. We also negotiate the selling currency for our products with our customers to reduce the impact of currency fluctuations.
In the past, we have derived significant benefits from our relationship with Philips. These benefits included access to patents and intellectual property and research and development services, participation in Philips collective bargaining agreements and pension plans, participation in Philips insurance programs, the Philips credit facility, access to Philips information technology systems and export and purchasing services provided by Philips. Since May 21, 2001, when Philips ownership of our common stock was reduced to approximately 25%, we have incurred additional labor and operating costs. These costs have been partially offset by payments to us from Philips, which were to total up to $6.0 million over a three-year period pursuant to our separation agreement with Philips. The separation agreement provided that these payments would cease upon a change of control of FEI. Because of our expected merger with Veeco and related amendments to the agreements with Philips, we now estimate that these payments will terminate before the end of the three-year period and that FEI will receive a total of $4.5 million. Accordingly, an additional $1.1 million of these payments were recognized during the thirteen weeks ended June 30, 2002, for a total of $1.7 million during the quarter. During the twenty-six weeks ended June 30, 2002, we recognized a total of $2.3 million of these payments as an offset to expenses. We expect to recognize the remaining $0.8 million of this expense reduction in the third quarter of 2002, and nothing thereafter, assuming the merger closes when expected.
15
RESULTS OF OPERATIONS
The following table sets forth our statement of operations data as a percentage of net sales.
|
|
Thirteen Weeks Ended |
|
Twenty-Six Weeks Ended |
|
||||
|
|
July 1, |
|
June 30, |
|
July 1, |
|
June 30, |
|
|
|
2001 |
|
2002 |
|
2001 |
|
2002 |
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
100.0 |
% |
100.0 |
% |
100.0 |
% |
100.0 |
% |
Cost of sales |
|
49.3 |
|
54.6 |
|
50.6 |
|
53.7 |
|
Gross profit |
|
50.7 |
|
45.4 |
|
49.4 |
|
46.3 |
|
Research and development |
|
11.9 |
|
12.0 |
|
10.9 |
|
12.4 |
|
Selling, general and administrative |
|
19.2 |
|
20.4 |
|
18.8 |
|
20.5 |
|
Merger costs |
|
0.0 |
|
1.3 |
|
0.0 |
|
0.6 |
|
Amortization of purchased goodwill and technology |
|
1.8 |
|
1.4 |
|
1.7 |
|
1.4 |
|
Operating income |
|
17.8 |
|
10.3 |
|
18.0 |
|
11.4 |
|
Other expense, net |
|
(2.9 |
) |
(1.6 |
) |
(1.6 |
) |
(1.5 |
) |
Income before taxes |
|
15.0 |
|
8.7 |
|
16.4 |
|
9.9 |
|
Tax expense |
|
5.8 |
|
3.2 |
|
6.4 |
|
3.6 |
|
Net income |
|
9.1 |
% |
5.5 |
% |
10.0 |
% |
6.3 |
% |
Totals may not foot due to rounding.
Net Sales
Net sales include sales in our microelectronics, electron optics, components and service segments. Net sales for the thirteen weeks ended June 30, 2002 decreased $6.2 million (7%), and for the twenty-six weeks ended June 30, 2002 decreased $15.2 million (8%) compared to the corresponding periods in 2001.
|
|
Thirteen Weeks Ended |
|
Twenty-Six Weeks Ended |
|
||||||||
|
|
July 1, |
|
June 30, |
|
July 1, |
|
June 30, |
|
||||
|
|
2001 |
|
2002 |
|
2001 |
|
2002 |
|
||||
Net Sales by Segment: |
|
(in thousands ) |
|
||||||||||
Microelectronics |
|
$ |
44,795 |
|
$ |
32,379 |
|
$ |
92,820 |
|
$ |
68,850 |
|
Electron Optics |
|
31,743 |
|
36,492 |
|
58,725 |
|
66,682 |
|
||||
Components |
|
4,435 |
|
2,566 |
|
9,317 |
|
5,703 |
|
||||
Customer Service |
|
13,069 |
|
16,444 |
|
26,695 |
|
31,144 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
|
|
$ |
94,042 |
|
$ |
87,881 |
|
$ |
187,557 |
|
$ |
172,379 |
|
Microelectronics segment sales decreased $12.4 million (28%) in the second quarter of 2002 compared to the second quarter of 2001 and decreased $24.0 million (26%) for the twenty-six weeks ended June 30, 2002 compared to the same period in 2001. The decrease was due primarily to the worldwide downturn and weak market conditions in the semiconductor and data storage industries, partially off-set by increased sales of our lower-priced products from this segment into the industry and institute markets.
Electron optics segment sales increased $4.7 million (15%) in the second quarter and $8.0 million (14%) in the first half of 2002 compared to the same periods in 2001. Sales in this segment from our SEM products increased significantly due to strong demand for our new Quanta and Sirion SEM products, primarily in the industry and institute markets. The acquisition of the SIMS product line in June from Atomika also provided $0.9 million of the increase in second quarter electron optic sales.
Components segment sales decreased $1.9 million (42%) in the second quarter of 2002 and $3.6 million
16
(39%) in the first half of 2002 compared to the same periods in 2001. Our component segment sales were adversely affected by the worldwide semiconductor equipment downturn.
Service sales increased $3.4 million (26%) in the second quarter of 2002 and $4.4 million (17%) in the first half of 2002 compared to 2001. The increase in service segment sales was primarily the result of an increase in the number of systems under service contracts in our worldwide installed base, particularly with respect to microelectronics segment products which carry higher average service contract prices corresponding with their higher average unit selling prices.
|
|
Thirteen Weeks Ended |
|
Twenty-Six Weeks Ended |
|
||||||||
|
|
July 1, |
|
June 30, |
|
July 1, |
|
June 30, |
|
||||
|
|
(in thousands ) |
|
||||||||||
Net Sales by Geographic Region: |
|
|
|
|
|
|
|
|
|
||||
North America |
|
$ |
35,448 |
|
$ |
33,690 |
|
$ |
77,242 |
|
$ |
70,746 |
|
Europe |
|
33,936 |
|
28,906 |
|
49,978 |
|
52,803 |
|
||||
Asia Pacific Region |
|
24,658 |
|
25,285 |
|
60,337 |
|
48,830 |
|
||||
|
|
$ |
94,042 |
|
$ |
87,881 |
|
$ |
187,557 |
|
$ |
172,379 |
|
In North America, sales decreased by $1.8 million (5%) from the second quarter of 2001 to the second quarter of 2002 and decreased by $6.5 million (8%) from the first half of 2001 to the first half of 2002, primarily due to weak market conditions arising from the downturn in the semiconductor and data storage industries. In Europe, sales decreased by $5.0 million (15%) from the second quarter of 2001 to the second quarter of 2002 but increased by $2.8 million (6%) from the first half of 2001 to the first half of 2002, primarily due to stronger sales in the industry and institute markets for the comparable period. In the Asia Pacific region, sales increased by $0.6 million (3%) from the second quarter of 2001 to the second quarter of 2002 and decreased by $17.7 million (29%) from the first half of 2001 to the first half of 2002. Sales in the Asia Pacific region in the first quarter of 2001 were at record levels for FEI, driven by strength in the semiconductor and data storage markets in that region as well as seasonal trends arising from the fact that many Japanese customers have March 31 fiscal year ends. The Asia Pacific region has also been adversely affected in the first half of 2002 by overall depressed economic conditions.
Gross Profit
Cost of sales includes manufacturing costs such as materials, labor (both direct and indirect) and factory overhead, as well as all of the costs of our customer service function such as labor, materials, travel and overhead. Gross profit as a percentage of sales, or gross margin, was 45.4% for the second quarter of 2002 compared to 50.7% for the second quarter of 2001 and was 46.3% for the first half of 2002 compared to 49.4% for the first half of 2001.
Our gross margin has declined over the last year due to several factors. The most significant factor has been the change in our product mix. In general, our microelectronics products carry higher gross margins than our electron optics products and our service business, and microelectronics products have decreased from 49.5% of our year-to-date net sales in 2001 to 39.9% of our year-to-date net sales in 2002 as a result of lesser demand from our customers. Our margins in 2002 have also been affected by pricing pressure from competitors that have introduced new products into our markets or who benefit from favorable currency exchange movements in their home countries. We have also experienced cost increases in 2002 from some of our larger vendors. Our future gross margins could be affected by changes in product mix, further pricing pressure from competitors or by unfavorable movements in currency exchange rates. Our gross margins could also be adversely affected in the future by increases in our costs for component parts.
Research and Development Costs
Research and development, or R&D, costs include labor, materials, overhead and payments to Philips and other third parties incurred in research and development of new products and new software or enhancements to existing products and software. R&D costs decreased $0.6 million (5%) in the second quarter of 2002 and increased $0.9 million (4%) in the first half of 2002 compared to the same periods in 2001. R&D costs are reported net of
17
subsidies and capitalized software development costs. These offsets totaled $1.2 million and $2.1 million in the second quarter of 2001 and 2002, respectively, and were $1.8 million and $3.8 million in the first half of 2001 and 2002. Excluding the effects of these offsets, R&D costs increased $0.3 million (2%) in the second quarter of 2002 and $2.9 million (13%) in the first half of 2002 compared to the same periods in 2001. The increase in R&D costs in 2002 is primarily attributable to increases in engineering headcount, including employees added through two small acquisitions we made in the second half of 2001. We are continuing to invest in the development of product improvements and upgrades, new software systems and new products to broaden the product line offerings of our business segments. We expect our R&D costs to continue to increase in dollar amount over time.
Selling, General and Administrative Costs
Selling, general and administrative, or SG&A, costs include labor, travel, outside services and overhead incurred in our sales, marketing, management and administrative support functions. SG&A costs include sales commissions paid to our employees as well as to our agents. SG&A costs for the second quarter of 2002 decreased $0.1 million (1%) compared to the second quarter of 2001 and were flat for the first half of 2002 compared to the first half of 2001. As a percentage of sales, SG&A costs were 19.2% and 20.4% in the second quarter of 2001 and 2002, and were 18.8% and 20.5% in the first six months of 2001 and 2002, respectively. The increase in SG&A costs as a percentage of sales from 2001 to 2002 is primarily attributable to lower sales volumes and the fact that many SG&A costs are fixed or semi-fixed rather than variable in nature.
Merger Costs
During the second quarter of 2002, $1.1 million of legal and accounting costs were incurred and expensed in conjunction with the Companys announced intention to merge with Veeco Instruments. Please read also Agreement and Plan of Merger with Veeco Instruments, Inc. below. We expect to incur additional merger related costs of $9.0 million to $12.0 million for investment banking, legal and accounting fees if the merger closes as expected.
Amortization of Purchased Goodwill and Technology
In accordance with Statement of Financial Accounting Standards, or SFAS, No. 142, Goodwill and Other Intangible Assets, we no longer amortize purchased goodwill effective January 1, 2002. Under SFAS No. 142, amortization has been replaced with a periodic impairment test for goodwill. Read also Note 2 to the consolidated financial statements included elsewhere in this report and the heading Recently Issued Accounting Pronouncements below. Amortization of purchased goodwill and technology decreased $0.4 million from the second quarter of 2001 to the second quarter of 2002 and $0.8 million from the first half of 2001 to the first half of 2002. This change resulted from a decrease of $0.9 million and $1.7 million during the quarter and first six months resulting from the cessation of goodwill amortization, partially offset by $0.5 million and $0.9 million during the quarter and first six months of new amortization for purchased technology recorded from acquisitions made during 2001.
Other Income (Expense), Net
Interest income represents interest earned on the temporary investment of cash and cash equivalents, short term investments, and non-current investments. The increase in interest income in both the second quarter and first half of 2002 compared to the same periods of 2001 is the result of increased cash balances invested, partially offset by lower average interest rates. Interest rates decreased significantly during the second half of 2001 and have remained low through the first half of 2002. Completion of our common stock offering in May 2001 and our convertible debt offering in August 2001 provided additional cash that has been invested in both short-term and non-current marketable debt securities. Interest expense for the second quarter and first half of 2002 includes $2.4 million and $4.8 million for the convertible debt issued in August 2001. Interest expense in the second quarter and first half of 2001 represented interest incurred on borrowings under our bank line of credit facilities and on borrowings from Philips under the Philips credit facility.
In July 2001, the Company entered into a definitive agreement to purchase the assets of Surface Interface. As a result of this agreement, we adjusted the carrying value of our existing investment in Surface Interface to reflect the
18
purchase price in the definitive agreement. Accordingly, a valuation charge to earnings of $3.7 million was taken in the thirteen weeks ended July 1, 2001.
Income Tax Expense
Our effective income tax rate on income before taxes was 39.1% and 36.5% for the second quarter of 2001 and 2002, and 38.9% and 36.5% for the first six months of 2001 and 2002, respectively. Our effective tax rate differs from the U.S. federal statutory tax rate primarily as a result of the effects of state and foreign taxes and our use of a foreign sales corporation for exports from the U.S., research and experimentation tax credits earned in the U.S., the nondeductible write-off of purchased in-process research and development costs, the amortization of goodwill prior to January 1, 2002 that is not deductible for income tax purposes as well as other factors. The effective tax rate was higher in the second quarter and first half of 2001 compared to the same periods of 2002 primarily because of the amortization of non-deductible goodwill during 2001.
In addition to the factors mentioned above, our effective income tax rate on income before taxes can be affected by changes in statutory tax rates in the U.S. and foreign jurisdictions, our ability or inability to utilize various carry forward tax items, changes in tax laws in the U.S. governing research and experimentation credits and foreign sales corporations and other factors. The World Trade Organization recently ruled against the U.S. tax policies covering U.S. exports and it is unclear what action, if any, the U.S. government may take in response to this ruling. Therefore, we are not able to estimate the future effective income tax rate we may incur.
LIQUIDITY AND CAPITAL RESOURCES
Cash and cash equivalents increased by $10.2 million in the first six months of 2002 to $187.1 million as of June 30, 2002. Operating activities provided $9.4 million and $30.1 million of cash in the first half of 2002 and 2001, respectively. Excluding the effects of changes in working capital components, operating activities generated $24.4 million of cash in 2002 and $26.2 million of cash in 2001. The decrease in cash flows from operating activities in the first half of 2002 compared with the first half of 2001 was primarily due to lower net income and changes in working capital components.
Short-term investments decreased by $57.3 million in the first half of 2002 to $61.5 million as of June 30, 2002. These investments represent marketable debt securities which had maturities greater than 90 days when we purchased them. All such investments are scheduled to mature in less than 12 months from the balance sheet date. The decrease in short-term investments was offset by our purchase of non-current investments in the first half of 2002, which totaled $48.6 million at June 30, 2002. These non-current investments represent marketable debt securities, which are scheduled to mature more than 12 months from the balance sheet date. We intend to hold these securities to their maturity dates.
Accounts receivable increased $10.9 million from December 31, 2001 to June 30, 2002. Weakening of the dollar in relation to currencies of our foreign subsidiaries during the second quarter of 2002 resulted in $4.3 million of the increase from the translation of foreign receivables into U.S. dollars. Our days sales outstanding, or DSO, calculated on an end-of-quarter basis, increased from 77 days at December 31, 2001 to 95 days at June 30, 2002. Inventories increased $8.2 million from December 31, 2001 to June 30, 2002. The majority of this increase, $6.7 million, is due to currency changes, as our foreign currency denominated inventories are translated into U.S. dollars. The remaining increase was primarily due to the acquisition of assets from Atomika, Inc. As a result of this increase in inventory, our inventory turnover rate, calculated on an end-of-quarter basis, decreased from 2.7 at December 31, 2001 to 2.1 at June 30, 2002. Current liabilities increased $5.8 million from December 31, 2001 to June 30, 2002. This increase resulted from the translation of foreign currency liabilities into U.S. dollars, partially offset by payment of year-end accruals.
We incurred capital expenditures for acquisition of equipment of $10.3 million in the first half of 2002 and $12.4 million in the first half of 2001. These expenditures included application laboratory and demonstration systems, which exhibit the capabilities of our equipment to our customers and potential customers. We have expanded our demonstration capabilities over the last two years. We also invest in equipment for development,
19
manufacturing and testing purposes. We lease the real property used in our business. However, on July 30, 2002 we purchased land and two buildings in Hillsboro, Oregon, which are expected to cost a total of $23.0 million after improvements are completed. We plan to vacate our leased facilities in Oregon, and consolidate our operations into these newly acquired facilities. We expect the annual cost of the owned facilities to be less than the annual cost of our current leased facilities. We expect to continue to invest in capital expenditures to further expand our business, particularly for demonstration equipment and loaner systems. We also invest in internally developed software, which controls our equipment and provides information from the equipment for use by customers. We capitalized software development costs of $1.5 million in the first six months of 2002 and $0.5 million in the first half of 2001. We also expect to continue to invest in software development as we develop new software for our existing products and new products under development.
During the first quarter of 2002 we invested $1.0 million for a small equity position in a start-up company that manufactures metrology equipment for the semiconductor manufacturing industry. During the second quarter of 2002 we purchased all of the assets and assumed certain liabilities of Atomika, Inc., a supplier of secondary ion mass spectrometry equipment for $1.1 million in cash and the assumption of $1.6 million in liabilities. We expect to continue to use acquisition and investment opportunities to augment our growth and market position.
On July 30, 2001, we terminated our $75.0 million credit facility with Philips, and the outstanding balance was repaid in full. We currently have no plans to establish a replacement credit facility because of our anticipated merger with Veeco.
We also maintain a $10.0 million unsecured and uncommitted bank borrowing facility in the U.S. and various limited facilities in selected foreign countries. In addition, we maintain a $5.0 million unsecured and uncommitted bank facility in the U.S. and a $4.9 million facility in the Netherlands for the purpose of issuing standby letters of credit/bank guarantees. At June 30, 2002, we had outstanding standby letters of credit/bank guarantees totaling approximately $1.9 million to secure customer advance deposits under these bank facilities. We also had outstanding at June 30, 2002, $10.5 million of foreign bank guarantees that are secured by cash balances.
On August 3, 2001, we issued $175 million of convertible subordinated notes, due August 15, 2008, through a private offering. Our proceeds, net of underwriting discounts, commissions and debt issuance expenses, totaled $169.1 million. The notes are redeemable at our option beginning in 2004, or earlier if the price of our common stock exceeds specified levels. The notes bear interest at 5.5%, payable semi-annually in February and August. The notes are convertible into our common stock, at the note holders option, at a price of $49.52 per share at any time up through their maturity. We are using the proceeds of this note offering for working capital and general corporate purposes.
Operations are conducted in manufacturing and administrative facilities under operating leases that extend through 2006. The lease agreements generally provide for payment of base rental amounts plus our share of property taxes and common area costs. The leases generally provide renewal options at current market rates. Rent expense is recognized on a straight-line basis over the term of the lease. Rent expense was $1.6 million and $1.7 million for the second quarter of 2001 and 2002, and $3.0 million and $3.7 million for the first six months of 2001 and 2002, respectively.
On May 22, 2001, we completed a public offering of 3,066,666 shares of FEI common stock sold by us and 6,133,334 shares of FEI common stock sold by Philips. Our proceeds, net of underwriting discounts, commissions and offering expenses, totaled $88.0 million. We used $26.0 million of the proceeds from this stock offering to pay off the Philips line of credit and are using the remainder for working capital and general corporate purposes. With completion of the offering, Philips ownership of FEI common stock was reduced to approximately 8.1 million shares, or 25.6% of the total FEI common shares then outstanding, compared with 49.7% ownership prior to the offering.
We issue shares under our employee stock purchase plan, which enables employees to purchase our stock at a 15% discount to market price at fixed points in time. We also grant options to purchase our shares to many of our employees and directors as part of incentive and other compensation programs. During the first half of 2001, 162,355 shares were issued under these programs as compared to 209,445 shares issued in the first half of 2002. These programs generated cash of $2.0 million in the first half of 2001 and $2.9 million in the first half of 2002.
20
We assess liquidity needs by evaluating cash balances on hand, available borrowings under our credit facilities, working capital trends and expected cash flows from operating activities versus our investment needs. In consideration of these factors, we believe that we have adequate financial resources for at least the next 12 months.
RELATED-PARTY ACTIVITY
Philips - Philips maintained majority control of FEI from February 21, 1997 until May 22, 2001, when its ownership was reduced through a secondary public stock offering.
We purchase various goods and services from Philips and Philips also purchases goods and services from us. We entered into a separation agreement with Philips, effective December 31, 2000, that clarifies certain relationships and transactions between the parties. Certain terms of the agreement became effective May 22, 2001 or 120 days after May 22, 2001, the day Philips ownership fell below 45% of the Companys outstanding common stock. The agreement addresses, among other things, patents and intellectual property, research and development services, use of the Philips name and trademark, participation in Philips insurance programs and the Philips credit facility. Under the separation agreement, we no longer participate in certain Philips sponsored or administered programs. We continue to purchase certain of these services from Philips and certain other of these services are procured from other suppliers. The cost to procure these services from other suppliers and from Philips subsequent to May 22, 2001 is in excess of the amounts previously paid to Philips.
Prior to September 1, 2001, the Company participated in certain pension and collective bargaining arrangements made by Philips in The Netherlands. We have entered into our own pension and collective bargaining arrangements in The Netherlands effective September 1, 2001. The cost of these employee benefit arrangements in The Netherlands is in excess of the amounts previously paid under the Philips arrangements. Under terms of the separation agreement with Philips dated December 31, 2000, Philips was to pay up to $6.0 million to FEI over a three-year period to reduce the effect of these increased costs. These payments would terminate on a change of control of FEI, as defined in the agreement. Because of our expected merger with Veeco, we now estimate that these payments will terminate before the end of the three-year period and that FEI will receive a total of only $4.5 million. Accordingly, an additional $1.1 million of these payments were recognized during the thirteen weeks ended June 30, 2002, for a total of $1.7 million during the quarter. During the twenty-six weeks ended June 30, 2002, we recognized a total of $2.3 million of these payments as an offset to expenses. During the thirteen and twenty-six weeks ended July 1, 2001, we recognized none of these payments or expense offsets. We expect to recognize the remaining $0.8 million of this expense reduction in the third quarter of 2002, and nothing thereafter, assuming the merger closes when expected.
Certain Philips business units purchase our products and services for internal use. In addition, a substantial portion of the subassemblies included in our FIBs, TEMs and SEMs are purchased from Philips Enabling Technologies Group.
Accurel Vahe Sarkissian, FEIs President and Chief Executive Officer, owns a 50 percent interest in Accurel Systems International Corp. (Accurel), a provider of metrology services to the semiconductor and data storage markets. In the thirteen weeks ended March 31, 2002, the Company sold two systems to Accurel for an aggregate purchase price of $2.2 million. Accurel was extended payment terms of 5 years with 7% interest for one system and 3 years with 6.5% interest for the other. These transactions were reviewed and approved by the Companys board of directors. There were no system sales to Accurel in the thirteen weeks ended June 30, 2002. The Company also provides service to Accurel on several of the Companys products used by Accurel. Service revenue from Accurel was $0.1 million and $0.2 million in the thirteen and twenty-six weeks ended July 1, 2001 and $0.1 million and $0.2 million in the thirteen and twenty-six weeks ended June 30, 2002. The Company has also guaranteed certain third party leases of Accurel, up to a maximum of $0.5 million as of June 30, 2002.
Stock Purchase Loan On June 25, 1998, we loaned $1.1 million to Vahe Sarkissian, our President and Chief Executive Officer, for the purchase of restricted FEI stock. The loan was originally due June 25, 2002 and bore interest at a rate of 5.58%. Effective as of June 25, 2002, our board of directors approved an amendment to the loan to extend the due date of the loan to June 25, 2005 and to increase the interest rate to 5.75%.
21
AGREEMENT AND PLAN OF MERGER WITH VEECO INSTRUMENTS, INC.
On July 11, 2002, FEI entered into an Agreement and Plan of Merger, or Merger Agreement, by and among Veeco Instruments Inc., Venice Acquisition Corp., a wholly owned subsidiary of Veeco and FEI. Pursuant to the Merger Agreement, Venice Acquisition will merge with and into FEI, with the result that FEI shall be the surviving corporation and shall become a wholly owned subsidiary of Veeco. As a result of the merger, each share of FEI common stock issued and outstanding immediately prior to the effective time of the merger shall be converted into the right to receive 1.355 shares of Veeco common stock. In addition, Veeco will assume all options or other rights to purchase capital stock of FEI outstanding under FEIs existing stock option plans, including FEIs stock purchase plans and FEIs convertible debt. The consummation of the Merger, which is expected in the fourth quarter of 2002, is subject to the approval of the shareholders of FEI and Veeco, expiration or termination of certain waiting periods under United States and applicable foreign antitrust laws, SEC clearance and other customary closing conditions. On August 12, 2002, the Antitrust Division of the Department of Justice contacted the Company and advised us that it intends to conduct a preliminary inquiry into the transaction. The merger is intended to be a tax-free reorganization under Section 368(a) of the Internal Revenue Code of 1986, as amended.
For more information concerning the merger and related transactions, including risks and uncertainties related to the merger and these transactions, please see the Registration Statement on Form S-4 filed by Veeco with the SEC in connection with the merger (File No. 333-97977). FEI shareholders as of the record date for voting on the merger will also receive a joint proxy statement/prospectus, which is a part of the Form S-4. The joint proxy statement/prospectus contains important information about the merger and FEI shareholders are urged to review it carefully.
SIGNIFICANT ACCOUNTING POLICIES AND ESTIMATES
The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Significant estimates underlying the accompanying consolidated financial statements include the allowance for doubtful accounts, reserves for excess or obsolete inventory, warranty liabilities, income tax related contingencies, the lives and recoverability of equipment and other long-lived assets such as existing technology intangibles and goodwill, and the timing of revenue recognition. It is reasonably possible the estimates may change in the near future.
The allowance for doubtful accounts is estimated based on past collection experience, known trends with current customers, and the need for a general overall reserve against receivables to cover unknown future collection problems. The large number of entities comprising our customer base and their dispersion across many different industries and geographies somewhat mitigates our credit risk exposure and the magnitude of our allowance for doubtful accounts.
Inventory is stated at lower of cost or market with cost determined by standard cost methods, which approximate the first-in, first-out method. Inventory costs include material, labor and manufacturing overhead. Reserves for inventory obsolescence and excess quantities are established based on estimated future use of quantities on hand, which is determined based on past usage, planned changes to products, and known trends in markets and technology. Because of the long-lived nature of many of our products, we maintain a substantial supply of parts for possible use in future repairs and customer field service. As these service parts become older, we apply a higher percentage of reserve against the recorded balance, recognizing that the older the part, the less likely it is to ultimately be used.
Purchased goodwill, which represents the excess of cost over the fair value of net assets acquired in a business combination, was amortized through December 31, 2001 on a straight-line basis over the estimated economic life for acquisitions made before July 1, 2001. For acquisitions made after June 30, 2001, purchased goodwill was not amortized. Effective January 1, 2002, none of our purchased goodwill is being amortized. We must periodically evaluate the fair value of purchased goodwill and determine if there has been any impairment in the recorded value. See also the heading Recently Issued Accounting Pronouncements below.
22
Existing technology intangible assets purchased in a business combination, which represent the estimated value of products utilizing technology existing as of the acquisition date discounted to their net present value, are amortized on a straight-line basis over the estimated useful life of the technology. We are currently using amortization periods ranging from 5 years to 12 years for these assets. Changes in technology could affect our estimate of the useful lives of such assets. Please also read Note 2 of the consolidated financial statements included elsewhere in this report.
We capitalize certain software development costs for software expected to be sold within our products. Such costs are capitalized after the technological feasibility of the project is determined and are reported on the balance sheet in other assets. Once we begin to include such software in our products, these costs are amortized over the estimated economic life of the software, which is usually 3 years. Changes in technology could affect our estimate of the useful life of such assets.
We evaluate the remaining life and recoverability of equipment and other assets, including intangible assets, whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If there is an indication of impairment, we prepare an estimate of future, undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying value of the asset, we adjust the carrying amount of the asset to its estimated fair value.
Our products generally carry a one-year warranty. A reserve is established at the time of sale to cover estimated warranty costs and certain commitments for product upgrades. Our estimate of warranty cost is based primarily on our history of warranty repairs and maintenance. For our new products without a history of known warranty costs, we estimate the expected costs based on our experience with similar product lines and technology. While most new products are extensions of existing technology, the estimate could change if new products require a significantly different level of repair and maintenance than similar products have required in the past.
For products produced according to our published specifications, revenue is recognized when the title to the product and the risks and rewards of ownership pass to the customer. For products produced according to a particular customers specifications, revenue is recognized when the product meets the customers specifications and when the title and the risks and rewards of ownership have passed to the customer. In each case, the portion of revenue applicable to installation and final customer acceptance is recognized upon meeting specifications at the installation site. For new applications of the Companys products where performance cannot be assured prior to meeting specifications at the installation site, no revenue is recognized until such specifications are met.
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
We adopted Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and Other Intangible Assets on January 1, 2002. The statement requires discontinuing the amortization of goodwill and other intangible assets with indefinite useful lives. Instead, these assets are to be tested periodically for impairment and written down to their fair market value as necessary. Other than the cessation of amortization of goodwill, the adoption of SFAS No. 142 had no effect on our results of operations or cash flows for the thirteen or twenty-six weeks ended June 30, 2002. The amount of goodwill amortization expense was $896 for the thirteen weeks and $1,683 for the twenty-six weeks ended July 1, 2001. As part of the adoption of SFAS No. 142, we were required to complete an impairment test on existing goodwill by June 30, 2002 and annually thereafter. We completed this impairment test during the thirteen weeks ended June 30, 2002 and determined there was no impairment to our existing goodwill. SFAS No. 142 did not effect the accounting treatment for our other purchased technology such as existing technology and in-process research and development.
SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, was issued in August 2001 and became effective January 1, 2002. SFAS No. 144 supersedes SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of and APB Opinion No. 30, Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions. SFAS No. 144 establishes a single accounting model for long-lived assets to be disposed of by sale and expands on the guidance provided by SFAS No. 121 with respect to cash flow estimations. The adoption of
23
SFAS No. 144 did not have a material effect on our financial position, results of operations or cash flows.
SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections, was issued in April 2002. This statement rescinds SFAS No. 4 and its amendments, which required all gains and losses from extinguishments of debt to be aggregated and, if material, classified as an extraordinary item, net of related income tax effects. We do not believe that the adoption of SFAS No. 145 will have a material effect on our financial position, results of operations or cash flows.
On July 30, 2002, FASB issued SFAS no. 146, Accounting for Costs Associated with Exit or Disposal Activities. SFAS No. 146 requires companies recognize costs associated with exit or disposal activities when they are incurred rather than at the date of a commitment to an exit or disposal plan. SFAS No. 146 is to be applied prospectively to exit or disposal activities initiated after December 31, 2002. The Company does not believe the adoption of this statement will have a material impact on its financial position, results of operations, or cash flows.
From time to time we may make forward-looking statements that are subject to a number of risks and uncertainties. The statements in this report concerning increased investment in plant and equipment and software development, the portions of our sales consisting of international sales, expected capital requirements, estimates of increased labor costs, use of acquisition and investment opportunities to augment growth, use of investments in capital expenditures and increasing research and development costs to broaden the product line offerings of our business segments and the expected completion of our merger with Veeco constitute forward-looking statements that are subject to risks and uncertainties. Factors that could materially decrease our investment in plant and equipment and software development include, but are not limited to, downturns in the semiconductor manufacturing market, lower than expected customer orders and changes in product sales mix. Factors that could materially reduce the portion of our sales consisting of international sales include, but are not limited to, competitive factors, including increased international competition, new product offerings by competitors and price pressures, fluctuations in interest and exchange rates (including changes in relevant foreign currency exchange rates between time of sale and time of payment), changes in trade policies, tariff regulations and business conditions and growth in the electronics industry and general economies, both domestic and foreign. Factors that could materially increase our capital requirements include, but are not limited to, receipt of a significant portion of customer orders and product shipments near the end of a quarter and the other factors listed above. Factors that could increase our labor costs include, but are not limited to, a tighter labor market, general economic conditions and competitive factors. Factors that could materially reduce our investments in capital expenditures and research and development costs include, but are not limited to, our ability to successfully execute our business plan in each of our business segments, customer demand for our existing products and new products, new product offerings of our competitors and the other factors listed above. Factors that could affect our ability to augment our growth using acquisition and investment opportunities include, but are not limited to, business conditions and growth in the electronics industry and general economies, our ability to successfully locate and develop investment relationships or acquisition opportunities with other companies in our industry and the ability to integrate the operations of any acquisitions with our operations to grow our business. Factors that could delay the closing date or cancel the plan of merger with Veeco include, but are not limited to, the timing and results of shareholder votes by both FEI and Veeco and the timing and results of regulatory reviews.
Exchange Rate Sensitivity
A large portion of our business is conducted outside of the U.S. through a number of foreign subsidiaries. Each of the foreign subsidiaries keeps its accounting records in its respective local currency. These local currency denominated accounting records are translated at exchange rates which fluctuate up or down from period to period and consequently affect the consolidated results of operations and financial position. The major foreign currencies in which we face periodic fluctuations are the euro, the Czech koruna, the Japanese yen and the British pound sterling. Although for each of the last two years more than 55% of our sales occurred outside of the U.S., a large portion of
24
these foreign sales were denominated in U.S. dollars and euros. Assets and liabilities of foreign subsidiaries are translated using the exchange rates in effect at the balance sheet date. The resulting translation adjustments increased shareholders equity and comprehensive income for the first six months of 2002 by $8.1 million.
We do not enter into derivative financial instruments for speculative purposes. From time to time we enter into forward sale or purchase contracts for foreign currencies to hedge specific receivables or payables positions. As of June 30, 2002, the aggregate stated amount of these contracts was $35.5 million. Holding other variables constant, if the U.S. dollar weakened by 10%, the market value of foreign currency contracts outstanding as of June 30, 2002 would decrease by approximately $3.1 million. The decrease in value would be substantially offset from the revaluation of the underlying hedged transactions.
Since we have no variable interest rate debt outstanding at June 30, 2002, we would not experience a material adverse affect on our income before taxes as the result of a 1% increase in short-term interest rates.
We maintain an investment portfolio consisting primarily of fixed rate commercial paper, corporate bonds, bonds issued by the U.S. government or its agencies and other fixed rate securities, with maturities of less than two years. An increase or decrease in interest rates of 1% would not have an immediate material impact on our results of operations, financial position or cash flows, as we have the intent and ability to hold these fixed rate investments until maturity. However, as these investments mature and are re-invested at current available interest rates, the weighted average interest rate on our investment portfolio is affected by changes in short-term interest rates. A change of 1% in these short-term interest rates would eventually have a material affect on our results of operations and cash flows, by affecting the interest income we earn on this investment portfolio.
25
On May 16, 2001 at the Companys Annual Meeting of Shareholders, the holders of the Companys outstanding Common Stock took the actions described below. As of the record date for the Annual Meeting, 32,265,328 shares of Common Stock were issued and outstanding.
1. The shareholders elected each of Michael J. Attardo, Wilfred J. Corrigan, William E. Curran, Dr. William W. Lattin, Jan C. Lobbezoo, Gerhard Parker, Vahé A. Sarkissian and Donald R. VanLuvanee by the votes indicated below, to serve on the Companys Board of Directors for the ensuing year:
Michael J. Attardo |
|
|
29,886,477 |
|
shares in favor |
216,400 |
|
shares against or withheld |
|
|
|
Wilfred J. Corrigan |
|
|
29,909,312 |
|
shares in favor |
193,565 |
|
shares against or withheld |
|
|
|
William E. Curran |
|
|
29,608,124 |
|
shares in favor |
494,753 |
|
shares against or withheld |
|
|
|
Dr. William W. Lattin |
|
|
29,910,387 |
|
shares in favor |
192,490 |
|
shares against or withheld |
|
|
|
Jan C. Lobbezoo |
|
|
29,587,044 |
|
shares in favor |
515,833 |
|
shares against or withheld |
|
|
|
Dr. Gerhard Parker |
|
|
29,910,387 |
|
shares in favor |
192,490 |
|
shares against or withheld |
|
|
|
Vahé A. Sarkissian |
|
|
22,810,779 |
|
shares in favor |
7,292,098 |
|
shares against or withheld |
|
|
|
Donald R. VanLuvanee |
|
|
29,886,387 |
|
shares in favor |
216,490 |
|
shares against or withheld |
2. The shareholders voted to amend the Companys 1995 Stock Incentive Plan (i) to increase the number of shares of common stock reserved for issuance under the plan to 6,500,000; and (ii) effective as of January 1, 2001, to increase the number of shares subject to options or stock appreciation rights that may be granted to any employee in any single year, subsequent to the initial grant, from 100,000 to 200,000, by the votes indicated below:
23,468,864 |
|
shares in favor |
6,593,241 |
|
shares against or withheld |
40,772 |
|
shares abstaining |
26
(a) Exhibits
Exhibit 10.22 Amendment No. 1, dated as of June 24, 2002 to Non-Negotiable Promissory Note, dated as of June 25, 1998, between the Registrant and Vahe Sarkissian.
Exhibit 99.1 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(b) Reports on Form 8-K
None.
27
In accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
FEI COMPANY |
|
|
|
|
Dated: August 14, 2002 |
|
|
/s/ VAHÉ A. SARKISSIAN |
|
|
|
Vahé A. Sarkissian |
|
|
|
President and |
|
|
|
Chief Executive Officer |
|
|
|
|
|
|
|
/s/ STEPHEN F. LOUGHLIN |
|
|
|
Stephen F. Loughlin |
|
|
|
Vice President of Finance and |
|
|
|
Acting Chief Financial Officer |
28